ADD A CATEGORY
JUN 15, 2013 - Barron\'s
A Must Read - Share
Biotech giant Amgen is slimming costs and returning cash to shareholders. Even after a 43% run in the past year, the stock still looks attractive.
Hey you have no friends!!! Get to work and start inviting friends to help build your Comunitee. Click Here to invite friends.
© 2011 Comunitee, Inc.